Welcome to our dedicated page for Meritage Homes Corporation news (Ticker: $MTH), a resource for investors and traders seeking the latest updates and insights on Meritage Homes Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Meritage Homes Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Meritage Homes Corporation's position in the market.
Meritage Homes has announced that it is commencing an offering of $500 million in Convertible Senior Notes due 2028, with additional notes available. The notes will be senior, unsecured obligations of the Company and will be guaranteed by its subsidiaries. Interest on the notes will be payable semi-annually. The Company plans to use the proceeds for capped call transactions, redeeming existing notes, and general corporate purposes.
Meritage Homes (NYSE: MTH) will host a two-part series of investor day webcast calls covering key strategic topics like a new business model, long-term targets, land financing updates, and capital allocation. The calls will feature chief executive officer Phillippe Lord and chief financial officer Hilla Sferruzza, with guest hosts equity analysts Alan Ratner and Stephen Kim. Registration is required for the calls, which will include a question-and-answer session for participants.